Clinical Trial Update: Rituximab Effect on Decreasing glUcoCorticoid Exposition in PolyMyalgia Rheumatica Patients Recently Diagnosed [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated whether rituximab can decrease glucocorticoid exposure in patients recently diagnosed with polymyalgia rheumatica and the study has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polymyalgia Rheumatica

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Sint Maartenskliniek | Conditions: Polymyalgia Rheumatica | Phase 3 | Status: COMPLETED